Serial Number
98035456
Owner
Pearl Health, Inc.Attorney
CHRISTINA M. LICURSIFirst Use Date
Dec 21, 2020
Filing Date
Jun 9, 2023
PEARL Trademark
Serial Number: 98035456 • Registration: 8191174
Trademark Classes
Owner Contact Info
Legal Representation
Correspondence Address
CHRISTINA M. LICURSI WOLF, GREENFIELD & SACKS, P.C.
600 ATLANTIC AVENUE
BOSTON, MA 02210-2206
UNITED STATES
Trademark Details
Filing Date
June 9, 2023
Registration Date
March 31, 2026
First Use Anywhere
December 21, 2020
First Use in Commerce
December 21, 2020
Published for Opposition
February 10, 2026
Goods & Services
Business data analysis services in the field of healthcare; business management support services in the field of healthcare, namely, healthcare operations management assisting primary care physicians, health plans, and health networks to provide coordinated care and/or improve patient outcomes and satisfaction through implementation of business strategies and business processes for data analysis, population health management and care management services; business consulting in the field of healthcare practice operations management, namely, providing practice organization, management and administrative support services to individual physicians or small group practices; business management consulting services in the field of data and workflow of clinical documentation improvement programs; business management consulting services in the field of data analytics and business data management services to support operational and financial workflows for individual physicians or small group practices; business management consulting services in the field of physician advisor services; health care utilization and review services; business information and business data compiling and analyzing relating to business management for individual physicians or small group practices; managed care services, namely, utilization review and pre-certification services for individual physicians or small group practices; pharmaceutical cost management services and drug utilization review services
